Resource utilization in children with tuberous sclerosis complex and associated seizures: A retrospective chart review study

Journal of Child Neurology

Volumn 28, Issue 4, 2013, Pages 461-469

  Lennert, Barb ^a   Farrelly, Eileen ^a   Sacco, Patricia ^b   Pira, Geraldine ^c   Frost, Michael ^c  

^a XCENDA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c MINNESOTA EPILEPSY GROUP   (United States)

Author keywords

economic burden; epilepsy; resource utilization; seizures; tuberous sclerosis complex (TSC)

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLONAZEPAM; CLORAZEPATE; CORTICOSTEROID; CORTICOTROPIN; DIAZEPAM; ETHOSUXIMIDE; ETHOTOIN; ETIRACETAM; EVEROLIMUS; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; MESUXIMIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; RUFINAMIDE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CHILD; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMOGRAPHY; DIAGNOSTIC TEST; DISEASE COURSE; ELECTROENCEPHALOGRAM; FEMALE; FOSTER CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOME CARE; HOSPITALIZATION; HUMAN; INFANT; INFANTILE SPASM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; REHABILITATION CENTER; RETROSPECTIVE STUDY; REVIEW; SEIZURE; TUBEROUS SCLEROSIS;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 84875310640     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073812448437     Document Type: Review

References (41)

1. National Institute of Neurological Disorders and Stroke. Tuberous sclerosis fact sheet. Available at: http://www.ninds.nih.gov/disorders/tuberous- sclerosis/detail-tuberous-sclerosis.htm. Accessed September 19, 2011.
2. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001 ; 68: 64-80
3. Curatolo P, D'Argenzio L, Cerminara C, Bombardieri R. Management of epilepsy in tuberous sclerosis complex. Expert Rev Neurother. 2008 ; 8: 457-467
4. Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010 ; 51: 1236-1241
5. Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatr Drugs. 2008 ; 10: 299-313
6. Holmes GL, Stafstrom CE. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia. 2007 ; 48: 617-630
7. Kalantari BN, Salamon N. Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging. AJR Am J Roentgenol. 2008 ; 190: W304 - W309
8. Shepherd CW, Beard CM, Gomez MR, Kurland LT, Whisnant JP. Tuberous sclerosis complex in Olmsted County, Minnesota, 1950-1989. Arch Neurol. 1991 ; 48: 400-401
9. Thiele EA. Managing epilepsy in tuberous sclerosis complex. J Child Neurol. 2004 ; 19: 680-686
10. Tuberous Sclerosis Association. Clinical guidelines for the care of patients with tuberous sclerosis complex: summary. Available at: http://www.tuberous-sclerosis.org/publications/clinical-guidelines-for-the-care- of-patients-with-TSC.pdf. Accessed September 19, 2011.
11. Devlin LA, Shepherd CH, Crawford H, Morrison PJ. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland. Dev Med Child Neurol. 2006 ; 48: 495-499
12. de Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007 ; 16: 16-24
13. O'Callaghan F. Tuberous sclerosis complex. Pediatr Child Health. 2007 ; 18: 30-36
14. Ohtsuka Y, Ohmori I, Oka E. Long-term follow-up of childhood epilepsy associated with tuberous sclerosis. Epilepsia. 1998 ; 39: 1158-1163
15. Liang S, Li A, Zhao M, et al. Epilepsy surgery in tuberous sclerosis complex: emphasis on surgical candidate and neuropsychology. Epilepsia. 2010 ; 51: 2316-2321
16. Moavero R, Cerminara C, Curatolo P. Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. Childs Nerv Syst. 2010 ; 26: 1495-1504
17. Connolly MB, Hendson G, Steinbok P. Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects. Childs Nerv Syst. 2006 ; 22: 896-908
18. Roth J, Olasunkanmi A, MacAllister WS, et al. Quality of life following epilepsy surgery for children with tuberous sclerosis complex. Epilepsy Behav. 2011 ; 20: 561-565
19. Karenfort M, Kruse B, Freitag H, Pannek H, Tuxhorn I. Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex. Neuropediatrics. 2002 ; 33: 255-261
20. de Vries P, Humphrey A, McCartney D, Prather P, Bolton P, Hunt A;, TSC Behaviour Consensus Panel. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in tuberous sclerosis. Eur Child Adolesc Psychiatry. 2005 ; 14: 183-190
21. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006 ; 355: 1345-1356
22. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998 ; 13: 624-628
23. Bombardieri R, Pinci M, Moavero R, Cerminara C, Curatolo P. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol. 2010 ; 14: 146-149
24. Hallett L, Foster T, Liu Z, Blieden M, Valentim J. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin. 2011 ; 27: 1571-1583
25. Anisya-Vasanth AV, Satishchandra P, Nagaraja D, Swamy HS, Jayakumar PN. Spectrum of epilepsy in tuberous sclerosis. Neurol India. 2004 ; 52: 210-212
26. Beghi E, Frigeni B, Beghi M, De Compadri P, Garattini L. A review of the costs of managing childhood epilepsy. Pharmacoeconomics. 2005 ; 23: 27-45
27. Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D. Uptake and costs of care for epilepsy: findings from a U.K. regional study. Epilepsia. 1998 ; 39: 776-786
28. Pillas D, Selai C. Economic aspects of epilepsy and antiepileptic treatment: a review of the literature. Expert Rev Pharmacoecon Outcomes Res. 2005 ; 5: 327-338
29. Yoon D, Frick KD, Carr DA, Austin JK. Economic impact of epilepsy in the United States. Epilepsia. 2009 ; 50: 2186-2191
30. Romanelli P, Verdecchia M, Rodas R, Seri S, Curatolo P. Epilepsy surgery for tuberous sclerosis. Pediatr Neurol. 2004 ; 31: 239-247
31. Weiner HL. Tuberous sclerosis and multiple tubers: localizing the epileptogenic zone. Epilepsia. 2004 ; 45 (suppl 4). 41-42
32. Lewis JC, Thomas HV, Murphy KC, Sampson JR. Genotype and psychological phenotype in tuberous sclerosis. J Med Genet. 2004 ; 41: 203-207
33. Raznahan A, Higgins NP, Griffiths PD, Humphrey A, Yates JR, Bolton PF. Biological markers of intellectual disability in tuberous sclerosis. Psychol Med. 2007 ; 37: 1293-1304
34. Raznahan A, Joinson C, O'Callaghan F, Osborne JP, Bolton PF. Psychopathology in tuberous sclerosis: an overview and findings in a population-based sample of adults with tuberous sclerosis. J Intellect Disabil Res. 2006 ; 50 (pt 8). 561-569
35. Joinson C, O'Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med. 2003 ; 33: 335-344
36. Brooks-Kayal A. Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children. Epilepsia. 2011 ; 52 (suppl 1). 13-20
37. Curatolo P, Napolioni V, Moavero R. Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. J Child Neurol. 2010 ; 25: 873-880
38. Zaroff CM, Devinsky O, Miles D, Barr WB. Cognitive and behavioral correlates of tuberous sclerosis complex. J Child Neurol. 2004 ; 19: 847-852
39. Kurth T, Lewis BE, Walker AM. Health care resource utilization in patients with active epilepsy. Epilepsia. 2010 ; 51: 874-882
40. Ivanova JI, Birnbaum HG, Kidolezi Y, Qiu Y, Mallett D, Caleo S. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia. 2010 ; 51: 838-844
41. Hunt A. A comparison of the abilities, health and behaviour of 23 people with tuberous sclerosis at age 5 and as adults. J Appl Res Intellect Disabil. 1998 ; 11: 227-238